Self‐Promoting Targeted Delivery of Epigenetic Immunostimulants to Activate Breast Cancer Immunity via HDACs Downregulation and PD‐L1 Upregulation
2025 · Angewandte Chemie International Edition · 9 citations
https://doi.org/10.1002/anie.202502120
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
30
Citations
4
h-index
0
i10-index
Ziqi Liang is an academic researcher from National University of Singapore. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Microfluidic and Capillary Electrophoresis Applications & Immune cells in cancer. The author has an h-index of 4, co-authored 9 publications.
https://doi.org/10.1002/anie.202502120
https://doi.org/10.1039/d5sc01953b
Click to start Chat